PMID- 10522989 OWN - NLM STAT- MEDLINE DCOM- 19991104 LR - 20190607 IS - 0021-972X (Print) IS - 0021-972X (Linking) VI - 84 IP - 10 DP - 1999 Oct TI - A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene. PG - 3522-7 AB - We report a novel case of multiple endocrine neoplasia type 2A (MEN 2A) associated with two mutations of the protooncogene RET. One affects codon 634 and causes a cysteine to arginine substitution; the second at codon 640 causes an alanine to glycine substitution in the transmembrane region. The two mutations were present on the same RET allele and were detected in germline and tumor DNA. Both mutations were de novo, i.e. they were not found in the DNA of the parents or relatives. Immunohistochemical and RT-PCR analysis showed that the pheochromocytoma expressed calcitonin as well as both RET alleles. A cell line established from the tumor and propagated in culture sustained the expression of RET and calcitonin, as did the original pheochromocytoma. Because the patient presented with medullary thyroid carcinoma and pheochromocytoma without parathyroid gland involvement, we speculate that this clinical picture could be correlated with the two RET mutations and to the unusual calcitonin production. This is the first report of a MEN 2A case due to two mutations of the RET gene and associated with a calcitonin-producing pheochromocytoma. FAU - Tessitore, A AU - Tessitore A AD - Dipartimento di Biochimica e Biotecnologie Mediche e Ceinge, Centro di Ingegneria Genetica, Universita degli Studi di Napoli Federico II, Italy. FAU - Sinisi, A A AU - Sinisi AA FAU - Pasquali, D AU - Pasquali D FAU - Cardone, M AU - Cardone M FAU - Vitale, D AU - Vitale D FAU - Bellastella, A AU - Bellastella A FAU - Colantuoni, V AU - Colantuoni V LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Drosophila Proteins) RN - 0 (Proto-Oncogene Proteins) RN - 9007-12-9 (Calcitonin) RN - EC 2.7.10.1 (Proto-Oncogene Proteins c-ret) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (Ret protein, Drosophila) SB - IM MH - Adrenal Gland Neoplasms/genetics/metabolism/pathology MH - Adult MH - Alleles MH - Amino Acid Sequence/genetics MH - Amino Acid Substitution MH - Base Sequence/genetics MH - Calcitonin/metabolism MH - DNA Mutational Analysis MH - *Drosophila Proteins MH - Female MH - Humans MH - Immunohistochemistry MH - Multiple Endocrine Neoplasia Type 2a/*genetics/metabolism/pathology MH - Mutation/*genetics MH - Pheochromocytoma/genetics/metabolism/pathology MH - Polymerase Chain Reaction MH - Proto-Oncogene Proteins/*genetics MH - Proto-Oncogene Proteins c-ret MH - Receptor Protein-Tyrosine Kinases/*genetics MH - Tumor Cells, Cultured EDAT- 1999/10/16 00:00 MHDA- 1999/10/16 00:01 CRDT- 1999/10/16 00:00 PHST- 1999/10/16 00:00 [pubmed] PHST- 1999/10/16 00:01 [medline] PHST- 1999/10/16 00:00 [entrez] AID - 10.1210/jcem.84.10.6056 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 1999 Oct;84(10):3522-7. doi: 10.1210/jcem.84.10.6056.